Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
GermanyStudy of Sasanlimab with BCG or Alone for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Not Responding to BCG
GermanyStudy on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease
GermanyStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
GermanyStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
GermanyStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults
GermanyStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
GermanyStudy on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis
GermanyStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
GermanyStudy of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer
GermanyStudy on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
